Urology
Volume 75, Issue 2 , Pages 262-265 , February 2010

Prediction of Clear Cell Renal Cell Carcinoma by Integrity of Cell-free DNA in Serum

  • Feng Gang

      Affiliations

    • Department of Urology, CHU of St-Etienne, University Jean-Monnet, St-Etienne, France
    • Clinical Immunology Laboratory, CHU of St-Etienne, University Jean-Monnet, St-Etienne, France
    • Corresponding Author InformationReprint requests: Feng Gang, M.D., Clinical Immunology Laboratory, CHU of St-Etienne, 42055 St-Etienne Cedex 2, France
    • ,
  • Li Guorong

      Affiliations

    • Department of Urology, CHU of St-Etienne, University Jean-Monnet, St-Etienne, France
    • ,
  • Zhao An

      Affiliations

    • Clinical Immunology Laboratory, CHU of St-Etienne, University Jean-Monnet, St-Etienne, France
    • ,
  • Gentil-Perret Anne

      Affiliations

    • Department of Pathology, CHU of St-Etienne, University Jean-Monnet, St-Etienne, France
    • ,
  • Genin Christian

      Affiliations

    • Clinical Immunology Laboratory, CHU of St-Etienne, University Jean-Monnet, St-Etienne, France
    • ,
  • Tostain Jacques

      Affiliations

    • Department of Urology, CHU of St-Etienne, University Jean-Monnet, St-Etienne, France

Received 29 April 2009 ,Accepted 21 June 2009.

References 

  1. Chan AK, Chiu RW, Lo YM. Clinical Sciences Reviews Committee of the Association of Clinical Biochemists (Cell-free nucleic acids in plasma, serum, and urine: a new tool in molecular diagnosis). Ann Clin Biochem. 2003;40:122–130
  2. Boddy JL, Gal S, Malone PR, et al. Prospective study of quantitation of plasma DNA levels in the diagnosis of malignant versus benign prostate disease. Clin Cancer Res. 2005;11:1394–1399
  3. Gautschi O, Bigosch C, Huegli B, et al. Circulating deoxyribonucleic acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy. J Clin Oncol. 2004;22:4157–4164
  4. Jahr S, Hentze H, Englisch S, et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 2001;61:1659–1665
  5. Goebel G, Zitt M, Muller HM. Circulating nucleic acids in plasma or serum (CNAPS) as prognostic and predictive markers in patients with solid neoplasias. Dis Markers. 2005;21:105–120
  6. Lam NY, Rainer TH, Chan LY, et al. Time course of early and late changes in plasma DNA in trauma patients. Clin Chem. 2003;49:1286–1291
  7. Leung TN, Zhang J, Lau TK, et al. Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. Clin Chem. 2001;47:137–139
  8. Ellinger J, Wittkamp V, Albers P, et al. Cell-free circulating DNA: diagnostic value in patients with testicular germ cell cancer. J Urol. 2009;181:363–371
  9. Schwarzenbach H, Stoehlmacher J, Pantel K, et al. Detection and monitoring of cell-free DNA in blood of patients with colorectal cancer. Ann NY Acad Sci. 2008;1137:190–196
  10. Zachariah RR, Schmid S, Buerki N, et al. Levels of circulating cell-free nuclear and mitochondrial DNA in benign and malignant ovarian tumors. Obstet Gynecol. 2008;112:843–850
  11. Utting M, Werner W, Dahse R, et al. Microsatellite analysis of free tumor DNA in urine, serum, and plasma of patients: a minimally invasive method for the detection of bladder cancer. Clin Cancer Res. 2002;8:35–40
  12. Widschwendter A, Müller HM, Fiegl H, et al. DNA methylation in serum and tumors of cervical cancer patients. Clin Cancer Res. 2004;10:565–571
  13. Gocke CD, Benko FA, Kopreski MS, et al. P53 and APC mutations are detectable in the plasma and serum of patients with colorectal cancer (CRC) or adenomas. Ann NY Acad Sci. 2000;906:44–50
  14. Chang HW, Lee SM, Goodman SN, et al. Assessment of plasma DNA levels, allelic imbalance, and CA125 as diagnostic tests for cancer. J Natl Cancer Inst. 2002;94:1697–1703
  15. Jin Z, El-Deiry WS. Overview of cell death signaling pathways. Cancer Biol Ther. 2005;4:139–163
  16. Giacona MB, Ruben GC, Iczkowski KA, et al. Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls. Pancreas. 1998;17:89–97
  17. Jiang WW, Zahurak M, Goldenberg D, et al. Increased plasma DNA integrity index in head and neck cancer patients. Int J Cancer. 2006;119:2673–2676
  18. Umetani N, Kim J, Hiramatsu S, et al. Increased integrity of free circulating DNA in Sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats. Clin Chem. 2006;52:1062–1069
  19. Sobin LH, Wittekind C. International Union Against Cancer, UICC. In: TNM Classification of Malignant Tumors. 6th ed.. New York: Wiley; 2002;
  20. Fuhrman SA, Lasky LC, Limas C, et al. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982;6:655–663
  21. Cohen HT, McGovern FJ. Renal-cell carcinoma. N Engl J Med. 2005;353:2477–2790
  22. Mostofi FK, Davis CJ. WHO International Histological Classification of Tumors. Berlin: Springer; 1998;
  23. Siow WY, Yip SK, Tan PH, et al. Renal cell carcinoma: incidental detection and pathological staging. J R Coll Surg Edinb. 2000;45:291–295

 This research was supported by the Comité de la Loire de la Ligue Contre le Cancer.

 Feng Gang and Li Guorong have equally contributed to this work.

PII: S0090-4295(09)00899-1

doi: 10.1016/j.urology.2009.06.048

Urology
Volume 75, Issue 2 , Pages 262-265 , February 2010

Article Tools

* Image Usage & Resolution